Kiniksa Pharmaceuticals International Plc (KNSA)
80.79
+1.09
(+1.37%)
USD |
NASDAQ |
Oct 22, 16:00
80.72
-0.07
(-0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Enterprise Value : 5.783B for Oct. 22, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 22, 2026 | 5.783B |
| October 21, 2026 | 5.698B |
| October 20, 2026 | 5.969B |
| October 19, 2026 | 5.681B |
| October 16, 2026 | 5.611B |
| October 15, 2026 | 5.717B |
| October 14, 2026 | 5.631B |
| October 13, 2026 | 5.607B |
| October 12, 2026 | 5.662B |
| October 09, 2026 | 5.704B |
| October 08, 2026 | 5.624B |
| October 07, 2026 | 5.562B |
| October 06, 2026 | 5.494B |
| October 05, 2026 | 5.434B |
| October 02, 2026 | 5.393B |
| October 01, 2026 | 5.349B |
| September 30, 2026 | 5.301B |
| September 29, 2026 | 5.388B |
| September 28, 2026 | 5.417B |
| September 25, 2026 | 5.338B |
| September 24, 2026 | 5.358B |
| September 23, 2026 | 5.416B |
| September 22, 2026 | 5.565B |
| September 21, 2026 | 5.576B |
| September 18, 2026 | 5.506B |
| Date | Value |
|---|---|
| September 17, 2026 | 5.669B |
| September 16, 2026 | 5.536B |
| September 15, 2026 | 5.343B |
| September 14, 2026 | 5.455B |
| September 11, 2026 | 5.430B |
| September 10, 2026 | 5.447B |
| September 09, 2026 | 5.606B |
| September 08, 2026 | 5.494B |
| September 04, 2026 | 5.558B |
| September 03, 2026 | 5.758B |
| September 02, 2026 | 5.713B |
| September 01, 2026 | 5.665B |
| August 31, 2026 | 5.615B |
| August 28, 2026 | 5.572B |
| August 27, 2026 | 5.706B |
| August 26, 2026 | 5.618B |
| August 25, 2026 | 5.737B |
| August 24, 2026 | 5.673B |
| August 21, 2026 | 5.646B |
| August 20, 2026 | 5.602B |
| August 19, 2026 | 5.784B |
| August 18, 2026 | 5.682B |
| August 17, 2026 | 5.657B |
| August 14, 2026 | 5.468B |
| August 13, 2026 | 5.552B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | 25.43M |
| Revenue (Quarterly) | 243.60M |
| Total Expenses (Quarterly) | 218.17M |
| EPS Diluted (Quarterly) | 0.305 |
| Gross Profit Margin (Quarterly) | 54.10% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 1.22% |
| Operating Earnings Yield | 1.52% |
| Normalized Earnings Yield | 1.217 |